AB SCIEX announces commercial expansion in Brazil AB SCIEX.

This expansion represents Abdominal SCIEX’s increasing expenditure in Brazil, which really is a rapidly emerging innovator for scientific advancements in Latin America. AB SCIEX is changing indirect distribution with a direct model of product sales and support within Brazil to create brand-new opportunities for customer interactions, collaborations and innovation. Related StoriesUCPH, Beckman Coulter Genomics identify effects of cancer on protein signaling networks within human cellscaprotec bioanalytics released U.S. Patent for CCMS proteome evaluation technologyDenator forms a new Scientific Advisory Board’Abdominal SCIEX is a reliable partner with a large number of scientists around the world, including many Brazilian experts,’ said Mateus Campos, nation manager, AB SCIEX Brazil.Financial results for the first one fourth of 2012: Adjusted net revenue of $672.4 million for the 1st quarter of 2012, in comparison to $582.5 million for the 1st quarter of 2011. Adjusted cash-basis net income per diluted common talk about of $0.77 for the first quarter of 2012, compared to adjusted cash-basis net gain per diluted common share of $0.61 for the first quarter of 2011. Adjusted product and providers revenues from our Professional Diagnostics segment were $516.7 million in the first quarter of 2012, in comparison to adjusted net product and providers revenue of $409.8 million in the first quarter of 2011.9 million of incremental net revenue compared to the first quarter of 2011.